Home
Conditions
Neoplasms, Glandular and Epithelial

Clinical trial condition

Neoplasms, Glandular and Epithelial

Explore clinical trials studying Neoplasms, Glandular and Epithelial. Study availability and eligibility vary by location and protocol.

17 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Neoplasms, Glandular and Epithelial trial results

Recruiting

HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors

NCT03911388

Conditions: Astrocytoma, Astrocytoma, Cerebellar, Brain Diseases, +49 more
Locations: MD Anderson Cancer Center Houston, Texas, United States

University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States

Siteman Cancer Center at Washington University St Louis, Missouri, United States

View Trial Details

Recruiting

Efficacy and Safety of Multimodal Ablation Combined With PD-1 Monoclonal Antibody, Lenvatinib and TACE in the Treatment of Unresectable Primary Hepatocellular Carcinoma: A Single-Arm, Single-Center Clinical Study

NCT06794073

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +8 more
Locations: Zhongshan Hospital, Fudan University Shanghai, Shanghai Municipality, China

View Trial Details

Recruiting

Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian Cancer

NCT04519151

Conditions: Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +25 more
Locations: Sheba Medical center Ramat Gan, Israel

View Trial Details

Not yet recruiting

Multitargeted Recombinant Ad5 PSA/MUC-1/Brachyury-Based Immunotherapy (TriAdeno) Vaccine With IL-15 Superagonist N-803 in Participants With Clinically Localized Prostate Cancer Undergoing Active Surveillance

NCT07574541

Conditions: Adenocarcinoma, Carcinoma, Genital Diseases, +12 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, not recruiting

Bevacizumab in Adults With Recurrent Respiratory Papillomatosis (RRP)

NCT05797246

Conditions: Communicable Diseases, DNA Virus Infections, Disease Attributes, +18 more
Locations: National Institutes of Health Clinical Center Bethesda, Maryland, United States

View Trial Details

Active, not recruiting

Quality of Life After Primary TORS vs IMRT for Patients With Early-stage Oropharyngeal Squamous Cell Carcinoma

NCT04124198

Conditions: Carcinoma, Carcinoma, Squamous Cell, Communicable Diseases, +29 more
Locations: Aarhus University Hospital Aarhus, Denmark

Copenhagen University Hospital Rigshospitalet Copenhagen, Denmark

Odense University Hospital Odense, Denmark

View Trial Details

Active, not recruiting

AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian Cancer

NCT05617755

Conditions: Abdominal Neoplasm, Abdominal Neoplasms, Adnexal Diseases, +29 more
Locations: UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

U of Colorado Cancer Center - Anschutz Medical Campus Aurora, Colorado, United States

U of Iowa Health Care Iowa City, Iowa, United States

Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States

View Trial Details

Active, not recruiting

Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer

NCT04807166

Conditions: Adnexal Diseases, Angiogenesis, Anlotinib, +22 more
Locations: Huai'an First People's Hospital Huai'an, China

Nanjing Drum Tower Hospital Nanjing, China

Zhongda Hospital Southeast University Nanjing, China

The First Affiliated Hospital of Soochow University Suzhou, China

View Trial Details

Completed

Near Infrared Autofluorescence (NIRAF) Detection for Identifying Parathyroid Glands During Parathyroidectomy

NCT05152927

Conditions: Adenoma, Calcium Metabolism Disorders, Endocrine Gland Neoplasms, +16 more
Locations: University of California, San Francisco San Francisco, California, United States

View Trial Details

Completed

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

NCT03037385

Conditions: Adenocarcinoma, Adenocarcinoma, Papillary, Bronchial Diseases, +55 more
Locations: Mayo Clinic Hospital Phoenix, Arizona, United States

UC Irvine Medical Center Orange, California, United States

University of Colorado Anschutz Medical Campus Aurora, Colorado, United States

Georgetown University Medical Center Washington D.C., District of Columbia, United States

View all 71 locations

View Trial Details

Neoplasms, Glandular and Epithelial

Neoplasms, Glandular and Epithelial trial results

Related conditions